Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 105,000 | $2.64 | $277,200.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 6 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 565,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 42,500 | $4.10 | $174,250.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 5 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,530 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 80,000 | $4.10 | $328,000.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 4 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 418,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 63,750 | $2.46 | $156,825.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 3 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,030 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 85,000 | $2.54 | $215,900.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 2 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2019 Filed Mar 4, 2019 11:00 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 35,700 | $7.34 | $262,038.00 |
DisclosureSEC source: 0001683168-19-000530 · ownership.xml · nonDerivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,280 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 16:22 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 470,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000147 · ownership.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 470,000 Underlying: Common Stock · 470,000 shares Expires 2028-01-05 F1 · balance_after: On January 6, 2018, the reporting person was granted an option to purchase 470,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:24 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 105,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000150 · ownership.xml · derivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2028-01-05 F1 · balance_after: On January 06, 2018, the reporting person was granted an option to purchase 105,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:23 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 205,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000149 · ownership.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 205,000 Underlying: Common Stock · 205,000 shares Expires 2028-01-05 F1 · balance_after: On January 6, 2018, the reporting person was granted an option to purchase 205,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 15, 2019 Filed Jan 17, 2019 21:23 UTC |
Matsuda KazukoChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 295,000 | $0.00 Strike: $7.00 | $0.00 |
DisclosureSEC source: 0001683168-19-000148 · ownership.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 295,000 Underlying: Common Stock · 295,000 shares Expires 2028-01-05 F1 · balance_after: On January 6, 2018, the reporting person was granted an option to purchase 295,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2018. The Performance criteria for 2018 have been met, resulting in full vesting of the option. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 21:24 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 41,250 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001683168-19-000079 · ownership.xml · derivative · entry 2 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 41,250 shares Expires 2019-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/30/2009 date of grant and is now fully vested. Read SEC document |
| January 09, 2019 Filed Jan 11, 2019 21:24 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 41,250 | $2.20 | $90,750.00 |
DisclosureSEC source: 0001683168-19-000079 · ownership.xml · nonDerivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 930 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 06:04 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 18,572 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001683168-19-000025 · ownership.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,572 shares Expires 2019-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/30/2009 date of grant and is now fully vested. Read SEC document |
| January 03, 2019 Filed Jan 7, 2019 06:04 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionCommon Stock | 18,572 | $2.20 | $40,858.40 |
DisclosureSEC source: 0001683168-19-000025 · ownership.xml · nonDerivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 759,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 226 shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:08 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.34 | $0.00 |
DisclosureSEC source: 0001683168-18-001636 · nagao_f4-060718.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019, subject to continued service with the Company. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:07 UTC |
Kobayashi YutakaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.34 | $0.00 |
DisclosureSEC source: 0001683168-18-001635 · kobayashi_f4-060718.xml · derivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019, subject to continued service with the Company. Read SEC document |
| June 07, 2018 Filed Jun 8, 2018 20:07 UTC |
Ishizaka YoshioDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $9.34 | $0.00 |
DisclosureSEC source: 0001683168-18-001634 · ishizaka_f4-060718.xml · derivative · entry 1 Ishizaka Yoshio · CIK 0001603893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-06-06 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019, subject to continued service with the Company. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 16:31 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 50,003 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001683168-18-000614 · iwaki_f4.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,003 shares Expires 2019-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/30/2009 date of grant and is now fully vested. Read SEC document |
| March 05, 2018 Filed Mar 7, 2018 16:31 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionCommon Stock | 50,003 | $2.20 | $110,006.60 |
DisclosureSEC source: 0001683168-18-000614 · iwaki_f4.xml · nonDerivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 740,594 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 18:12 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000087 · iwaki_f4-010618.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 450,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 23:25 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000091 · okajima_f4-010618.xml · derivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 23:24 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000090 · obrien_f4-010618.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 200,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 06, 2018 Filed Jan 9, 2018 23:23 UTC |
Matsuda KazukoChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 280,000 | $0.00 Strike: $6.10 | $0.00 |
DisclosureSEC source: 0001683168-18-000089 · matsuda_f4-010618.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,000 Underlying: Common Stock · 280,000 shares Expires 2027-01-17 F1 · balance_after: On January 18, 2017, the reporting person was granted an option to purchase 280,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria for the fiscal year ended December 31, 2017. The Performance criteria for 2017 have been met, resulting in full vesting of the option. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 16:51 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 53,363 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001683168-18-000059 · iwaki_frm4.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,363 shares Expires 2018-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/7/2008 date of grant and is now fully vested. Read SEC document |
| January 03, 2018 Filed Jan 5, 2018 16:51 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionCommon Stock | 53,363 | $4.42 | $235,864.46 |
DisclosureSEC source: 0001683168-18-000059 · iwaki_frm4.xml · nonDerivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 690,591 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 20:03 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 48,000 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001683168-17-003308 · okajima_frm4.xml · derivative · entry 2 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 48,000 shares Expires 2018-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/7/2008 date of grant and is now fully vested. Read SEC document |
| December 12, 2017 Filed Dec 14, 2017 20:03 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
Exercise / conversionCommon Stock | 48,000 | $4.42 | $212,160.00 |
DisclosureSEC source: 0001683168-17-003308 · okajima_frm4.xml · nonDerivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 22:34 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001683168-17-002952 · nagao_frm4.xml · derivative · entry 2 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2027-11-08 F1 · derivative.exercise_date: The option vests in three equal installments on December 31, 2017, March 31, 2018 and June 30, 2018, subject to continued service with the Company. Read SEC document |
| November 09, 2017 Filed Nov 13, 2017 22:34 UTC |
Nagao HidekiDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $6.51 | $0.00 |
DisclosureSEC source: 0001683168-17-002952 · nagao_frm4.xml · derivative · entry 1 Nagao Hideki · CIK 0001315306 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-11-08 Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 08:15 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 21,067 | $0.00 Strike: $4.42 | $0.00 |
DisclosureSEC source: 0001683168-17-002840 · iwaki_frm4.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,067 shares Expires 2018-01-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 1/7/2008 date of grant and is now fully vested. Read SEC document |
| November 02, 2017 Filed Nov 6, 2017 08:15 UTC |
IWAKI YUICHIDirector · President and CEO
|
Exercise / conversionCommon Stock | 21,067 | $4.42 | $93,116.14 |
DisclosureSEC source: 0001683168-17-002840 · iwaki_frm4.xml · nonDerivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 637,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired under MediciNova's employee stock purchase plan, which are exempt under Rule 16b-3(c). Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 17:50 UTC |
Ishizaka YoshioDirector
|
PurchaseCommon Stock | 5,000 | $5.17 | $25,850.00 |
DisclosureSEC source: 0001683168-17-002204 · ishizaka_frm4.xml · nonDerivative · entry 1 Ishizaka Yoshio · CIK 0001603893 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 10,000 F1 · price: The reported shares were purchased with Japanese Yen in multiple transactions. The purchase price reported in Column 4 is a weighted average price reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchanges Commission, upon request, full information regarding the number of shares purchased at each separate prices. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 20:22 UTC |
Kobayashi YutakaDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001683168-17-001540 · kobayashi_f4.xml · derivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018 and June 30, 2018, subject to continued service with the Company. Read SEC document |
| June 08, 2017 Filed Jun 9, 2017 20:21 UTC |
Ishizaka YoshioDirector
|
GrantStock Option (Right to Buy) · Derivative | 20,000 | $0.00 Strike: $5.65 | $0.00 |
DisclosureSEC source: 0001683168-17-001539 · ishizaka_f4.xml · derivative · entry 1 Ishizaka Yoshio · CIK 0001603893 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-06-07 F1 · derivative.exercise_date: The option vests in four equal installments on September 30, 2017, December 31, 2017, March 31, 2018 and June 30, 2018, subject to continued service with the Company. Read SEC document |
| May 15, 2017 Filed May 16, 2017 18:52 UTC |
Kobayashi YutakaDirector
|
PurchaseCommon Stock | 1,000 | $5.60 | $5,600.00 |
DisclosureSEC source: 0001683168-17-001289 · kobayashi_frm4.xml · nonDerivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 25,000 F1 · price: The reported shares were purchased with Japanese Yen. The purchase price reported in Column 4 is reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. Read SEC document |
| May 12, 2017 Filed May 15, 2017 22:27 UTC |
Kobayashi YutakaDirector
|
PurchaseCommon Stock | 24,000 | $5.62 | $134,880.00 |
DisclosureSEC source: 0001683168-17-001277 · kobayashi_f4-051217.xml · nonDerivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 24,000 F1 · price: The reported shares were purchased with Japanese Yes in multiple transactions. The purchase price reported in Column 4 is an average price reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova, Inc., or the staff of the Securities and Exchanges Commission, upon request, full information regarding the number of shares purchased at each separate price. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 17:28 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 320,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000138 · iwaki_f4.xml · derivative · entry 1 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 320,000 Underlying: Common Stock · 320,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 320,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 22:31 UTC |
Okajima MasatsuneVP and Head of Japanese Office
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000141 · okajima_f4.xml · derivative · entry 1 Okajima Masatsune · CIK 0001374660 · VP and Head of Japanese Office 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 22:30 UTC |
OBrien GeoffreyVice President
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 115,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000140 · obrien_f4.xml · derivative · entry 1 OBrien Geoffrey · CIK 0001589471 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 115,000 Underlying: Common Stock · 115,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 115,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
| January 18, 2017 Filed Jan 20, 2017 22:29 UTC |
Matsuda KazukoChief Medical Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 170,000 | $0.00 Strike: $3.91 | $0.00 |
DisclosureSEC source: 0001683168-17-000139 · matsuda_f4.xml · derivative · entry 1 Matsuda Kazuko · CIK 0001531140 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170,000 Underlying: Common Stock · 170,000 shares Expires 2026-01-06 F1 · balance_after: On January 7, 2016, the reporting person was granted an option to purchase 170,000 shares of common stock. The option vests based on MNOV's satisfaction of certain performance criteria by December 31, 2016. The Performance criteria have been met, resulting in full vesting of the option. Read SEC document |
| September 15, 2016 Filed Sep 15, 2016 18:10 UTC |
Kobayashi YutakaDirector
|
PurchaseCommon Stock | 11,800 | $6.44 | $75,992.00 |
DisclosureSEC source: 0001683168-16-000124 · kobayashi_frm4.xml · nonDerivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,800 F1 · price: The reported shares were purchased with Japanese Yen in multiple transactions. The purchase price reported in Column 4 is a weighted average price at prices ranging from $6.39 to $6.47 inclusive, reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| September 09, 2016 Filed Sep 9, 2016 22:29 UTC |
Kobayashi YutakaDirector
|
PurchaseCommon Stock | 10,000 | $6.67 | $66,700.00 |
DisclosureSEC source: 0001683168-16-000061 · medicinova_f4-kobayashi.xml · nonDerivative · entry 1 Kobayashi Yutaka · CIK 0001589259 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 F1 · price: The reported shares were purchased with Japanese Yen in multiple transactions. The purchase price reported in Column 4 is a weighted average price at prices ranging from $6.65 to $6.68 inclusive, reflected in US Dollars, based on the applicable currency exchange rate in effect on the date of purchase, rounded to the nearest whole cent. The reporting person undertakes to provide to MediciNova, Inc., any security holder of MediciNova Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| July 13, 2011 Filed Apr 13, 2020 21:40 UTC |
IWAKI YUICHIDirector · President and CEO
|
GrantEmployee Stock option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.54 | $0.00 |
DisclosureSEC source: 0001683168-20-001157 · ownership.xml · derivative · entry 3 IWAKI YUICHI · CIK 0001263965 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common stock · 100,000 shares Expires 2021-07-12 F2 · date: Due to an administrative oversight this option award initially was not reported. F3 · derivative.exercise_date: The option vested over a period of 4 years in equal monthly installments from the 7/13/2011 date of grant and is now fully vested. F2 · balance_after: Due to an administrative oversight this option award initially was not reported. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.